Key Financial Data Of Group

STELLA PHARMA CORPORATION - Filing #7248023

Concept 2024-04-01 to
2025-03-31
As at
2025-03-31
As at
2024-03-31
2023-04-01 to
2024-03-31
As at
2023-03-31
2022-04-01 to
2023-03-31
2021-04-01 to
2022-03-31
As at
2022-03-31
2020-04-01 to
2021-03-31
As at
2021-03-31
Key financial data of group
Business results of group
Net sales
961,058,000 JPY
269,491,000 JPY
229,067,000 JPY
100,096,000 JPY
205,968,000 JPY
Ordinary profit (loss)
-137,869,000 JPY
-760,208,000 JPY
-775,974,000 JPY
-764,088,000 JPY
-656,392,000 JPY
Net assets
3,207,485,000 JPY
2,377,012,000 JPY
2,752,502,000 JPY
3,079,623,000 JPY
230,718,000 JPY
Total assets
5,417,104,000 JPY
3,820,622,000 JPY
4,329,053,000 JPY
4,718,649,000 JPY
2,048,524,000 JPY
Net assets per share
94.26
75.90
91.51
107.39
11.46
Basic earnings (loss) per share
-4.22
-24.66
-26.97
-27.34
-32.90
Diluted earnings per share
Equity-to-asset ratio
0.5921 xbrli:pure
0.6203 xbrli:pure
0.6335 xbrli:pure
0.6526 xbrli:pure
0.1126 xbrli:pure
Rate of return on equity
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
Price-earnings ratio
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
Net cash provided by (used in) operating activities
140,408,000 JPY
-876,837,000 JPY
-827,669,000 JPY
-1,081,129,000 JPY
-772,811,000 JPY
Net cash provided by (used in) investing activities
287,576,000 JPY
-9,010,000 JPY
-29,925,000 JPY
-350,562,000 JPY
-22,864,000 JPY
Net cash provided by (used in) financing activities
721,253,000 JPY
228,353,000 JPY
291,819,000 JPY
3,829,240,000 JPY
-332,402,000 JPY
Cash and cash equivalents
3,161,471,000 JPY
2,012,233,000 JPY
2,669,727,000 JPY
3,235,502,000 JPY
837,952,000 JPY
Number of employees
43 xbrli:pure
44 xbrli:pure
46 xbrli:pure
43 xbrli:pure
43 xbrli:pure
Average number of temporary employees
3 xbrli:pure
5 xbrli:pure
3 xbrli:pure
4 xbrli:pure
4 xbrli:pure

Talk to a Data Expert

Have a question? We'll get back to you promptly.